Maria G Castro

6PUBLICATIONS
64CO-AUTHORS
Electrochemical energy storage and conversionMedical devicesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 01, 2024
Epigenetic Reprogramming of Autophagy Leads to Uncovering a Novel Therapeutic Target for Mutant IDH1 Astrocytomas.

Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb

|Jan 24, 2023
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.

Stephen V Carney, Kaushik Banerjee, Anzar Mujeeb

|Sep 29, 2021
G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy.

Mahmoud S Alghamri, Brandon L McClellan, Ruthvik P Avvari

|Jan 24, 2020
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas.

Ricardo Gargini, Berta Segura-Collar, Beatriz Herránz

|Feb 15, 2019
IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

Felipe J Núñez, Flor M Mendez, Padma Kadiyala

Pageof 1